Self-defense of human sarcoma cells against cytolytic lymphoid cells of their host.

Abstract

Metastatic human sarcomas temporarily respond to radio-chemotherapy relapse and remain highly resistant to further combination chemotherapy as to a curative effect, including checkpoint control.